Chemiluminescent Probe for Enhanced Visualization of Renal Ischemia-Reperfusion Injury via Pyroglutamate Aminopeptidase-1 Activation
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.4c05838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Zhongkun Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei …. Hauptthemen laut MEDLINE: Reperfusion Injury, Kidney, Luminescent Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Anhui Medical University, National Natural Science Foundation of China, Natural Science Foundation of Anhui Higher Education Institutions.
Abstract (Originalsprache)
The absence of an effective imaging tool for diagnosing renal ischemia-reperfusion injury (RIRI) severely delays its treatment, and currently, no definitive clinical interventions are available. Pyroglutamate aminopeptidase-1 (PGP-1), a potential inflammatory cytokine, has shown considerable potential as a biomarker for tracing the inflammatory process in vivo. However, its exact role in the enhanced visualization of RIRI in complex biological systems has yet to be fully established. Chemiluminescence imaging (CLI) has proven to be one of the most promising diagnostic methods due to its ultrahigh-contrast imaging capabilities compared to fluorescence imaging. In this study, we developed an activatable Schaap's dioxetane chemiluminescent probe (PGP-PD) to explore the potential of PGP-1 as a marker for CLI of renal injury following ischemia-reperfusion, with the goal of achieving high-contrast in situ diagnostics for RIRI. In vitro, PGP-PD exhibited exceptional selectivity for exogenous PGP-1 and remarkable sensitivity, with a detection limit as low as 2.244 ng/mL. Moreover, in vivo studies successfully demonstrated a positive correlation between the RIRI and PGP-1 level. Notably, in situ imaging with PGP-PD generated a significant chemiluminescent signal within the RIRI-kidney, providing an exceptionally high contrast between injured and normal kidney tissue (∼9.4-fold) in the RIRI mouse model. We anticipate that this work may offer a valuable biomarker (PGP-1) and a powerful imaging tool for improving RIRI in situ diagnosis, thereby aiding treatment planning and surgical outcomes for RIRI patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China.
- Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, 103 Culture Road, Shenhe District, Shenyang 110016, China.
- Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei 230001, Anhui, China.
ORCID-Profile: Qunlin Zhang, Xiang Shi
Förderung
- Anhui Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Higher Education Institutions
Zitieren
APA
Wang, Z., Geng, T., Yue, X., Zheng, Z., Zhang, W., Pan, Z., Zhang, Q., & Shi, X. (2025). Chemiluminescent Probe for Enhanced Visualization of Renal Ischemia-Reperfusion Injury via Pyroglutamate Aminopeptidase-1 Activation. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c05838
Vancouver
Wang Z, Geng T, Yue X, Zheng Z, Zhang W, Pan Z, et al. Chemiluminescent Probe for Enhanced Visualization of Renal Ischemia-Reperfusion Injury via Pyroglutamate Aminopeptidase-1 Activation. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.4c05838
BibTeX
@article{Wang2025,
author = {Wang, Zhongkun and Geng, Tingting and Yue, Xiaoyi and Zheng, Zhixiong and Zhang, Wei and Pan, Zhen and Zhang, Qunlin and Shi, Xiang},
title = {Chemiluminescent Probe for Enhanced Visualization of Renal Ischemia-Reperfusion Injury via Pyroglutamate Aminopeptidase-1 Activation},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.4c05838}
}
EUVIMED